Baby KJ Makes Medical History As The First Ever Patient To Receive A Fully Personalized Gene-Editing Treatment For An Ultra-Rare Genetic Defect.

Just days after birth, it became clear that something was profoundly wrong with baby KJ. What should have been a joyful time quickly spiraled into a nightmare as the newborn’s health rapidly deteriorated. Doctors were initially left scrambling for answers, speculating it could be meningitis or sepsis, but standard treatments failed.

At only one week old, the family received a devastating diagnosis. Doctors revealed that KJ was suffering from CPS1 deficiency, an ultra-rare genetic disorder. This condition is so exceptionally rare that it affects a mere 1 in 1.3 million babies globally, and a tragic majority of infants do not survive past their first week of life.

Faced with these grim statistics, the medical team gently suggested comfort care, advising the parents to prepare for the worst. However, refusing to give up, his parents chose to fight for their son’s life.

Their courage paved the way for an unprecedented medical breakthrough. KJ has become the first patient in history to receive a fully personalized gene-editing treatment, engineered specifically to correct his unique genetic mutation. This custom therapy represents a monumental milestone in medicine, opening a new era of hope for rare diseases. Full story in the comments.